Kandra Naga Vishnu, Praveen Kumar Uppala, Yakaiah Vangoori, Siva Naga Koteswara Rao Gudhanti
Dr. Kandra Naga Vishnu1*, (Dr) Praveen Kumar Uppala2, Dr. Yakaiah Vangoori3, Dr. Siva Naga Koteswara Rao Gudhanti4
1Post Graduate, Department of Pharmacology, Santhiram Medical College and General Hospital, Nandyal, Kurnool, Andhra Pradesh.
2Pharmacovigilance Associate, National Coordination Center, Pharmacovigilance Program of India, (NCC PvPI), Indian Pharmacoepia Commission, Ghaziabad. Employment Id-291.
3Assistant Professor, Department of Pharmacology, Santhiram Medical College and General Hospital, Nandyal, Kurnool, Andhra Pradesh.
4Professor and Vice Principal, Dept.of Pharmaceutics, K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh India 522502.
Volume - 11,
Issue - 4,
Year - 2021
The novel Corona Virus Disease popularly known as COVID-19 brought all sectors to a temporary standstill since its first outbreak in Wuhan China in 2019. The rapid spread of this disease to all countries of the world made it to be declared a pandemic by the world health organization in the first quarter of the year 2020. This pandemic exposed the world population to the understanding of immunity since that was the only remedy at present to this new pandemic. The morbidity and mortality of this new virus were estimated across the globe by many institutions and organizations. The tropical regions where malaria epidemic is more pronounced is less affected by COVID-19 probably due to high immunity already developed by the population as a result of frequent malaria disease and regular use of anti-malarial drug.
Cite this article:
Kandra Naga Vishnu, Praveen Kumar Uppala, Yakaiah Vangoori, Siva Naga Koteswara Rao Gudhanti. A Review on Covid 19 Pandemic and its Global Effects. Asian Journal of Pharmaceutical Research. 2021; 11(4):242-6. doi: 10.52711/2231-5691.2021.00042
Kandra Naga Vishnu, Praveen Kumar Uppala, Yakaiah Vangoori, Siva Naga Koteswara Rao Gudhanti. A Review on Covid 19 Pandemic and its Global Effects. Asian Journal of Pharmaceutical Research. 2021; 11(4):242-6. doi: 10.52711/2231-5691.2021.00042 Available on: https://asianjpr.com/AbstractView.aspx?PID=2021-11-4-4
1. Mehta F.A et.al.Antiociceptive and anti-inflammatory activity of Achyranthes aspera extracts. Pharmacologyonline. 2009; 3: 978-985. 2. Guyton, A.C., and Hall, J.E. Textbook of Medical Physiology. Philadelphia : Elsevier Saunders; 2006.
2. Singh, A., Malhotra, S., and Subban, R. Anti-inflammatory and analgesic agents from Indian medicinal plants. International Journal of Integrative Biology. 2008; 1: 57–72.
3. USDA-NRCS. The Plants Database. Baton Rouge. USA: National Plant Data Center.; 2012.
4. Aziz A, Rahman,et.al.. 3-Acetoxy-6-benzoyloxyapagamide from Achyranthes aspera. Journal of Pharmaceutical Sciences. 2005; 4(2): 113-116.
5. Umamaheswari M,et.al. Anticataract and antioxidant activities of Achyranthes aspera Linn. Against glucose-induced cataractogenesis using goat lenses. Journal of Natural Product and Plant Resources. 2012; 2: 153-161.
6. Varuna, KM, Khan MU and Sharma PK.Review on A. aspera. Journal of Pharmacy Research.2010; 3: 714-717.
7. Organisation for Economic co-operation and development ,Test no.423/acute oral toxicity-acute toxic class method in the OECD guideline for testing of chemicals OECD.Rome:2001.
8. Bhosale Uma et.al. Antinociceptive evaluation of an ethanol extract of Achyranthes aspera (agadha) in animal models of Nociception. International Journal of Phytomedicine. 2010; 2: 440-445.